Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry

The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Primary Open-Angle Glaucoma Eye Diseases Glaucoma Glaucoma, Open-Angle Ocular Hypertension

Sex eligibility

All sexes

Study type

Observational

Primary location

Chico, California, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Consecutive subjects in whom implantation of the iStent is attempted

Exclusion criteria

Please refer to approved indications in Directions for Use

Treatment and study plan

iStent

Device

Primary outcomes

Rate of sight-threatening adverse events

Time frame: 36 months

Secondary outcomes

Other ocular adverse events

Time frame: 36 months

Sponsors and collaborators

Lead sponsor

Glaukos Corporation

Industry

Registry information

Important dates

Study start: 2013
Primary completion: 2016
Study completion: 2016
First posted: Apr 26, 2013
Registry last updated: Dec 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed